J

Common side effects of Janumet

Janumet is a medicine that you can purchase only with a doctor’s prescription. This medicine is prescribed by doctors to patients who are suffering from type 2 diabetes. Doctors usually recommend that you take Janumet with a proper diet routine and workout plan. Apart from this, doctors may also give Janumet in conjunction with other medicines.

This medicine is a mixture of two medications that are, sitagliptin and metformin. Both of these ingredients combine together to control high levels of blood sugar in people who have type 2 diabetes.

Individuals that have type 2 diabetes do not have a proper balance of insulin in their body, and thus, their blood sugar is not under control. Janumet comes into play here.

The medicine also reduces symptoms associated with high levels of blood sugar including kidney disease, blindness, damage to the nerves, sexual function issues, and other problems.

Common side effects of Januvia (Sitagliptin)

Januvia is an externally administered medication with Sitagliptin as its active ingredient. This active ingredient is an oral anti-hyperglycemic, i.e., an antidiabetic drug of the dipeptidyl peptidase-4 (DPP-4) inhibitor class.

Januvia is usually used as a medication to regulate blood sugar levels in diabetic patients, and indirectly prevent medical disorders like kidney damage, blindness, nerve problems, loss of limbs, heart attack, stroke, and sexual function problems.

It is important to note here that it is only effective for people with diabetes mellitus type 2, and thus, is not prescribed to patients with diabetes mellitus type 1. This medication may be used alone or with a combination of other antidiabetic medications.

Patients consuming Januvia may also be directed to exercise regularly and to take the medicine with their meals. It may also be prescribed for purposes not mentioned here.

This medicine is manufactured and sold in the form of tablets. The generic form of Januvia is not yet available. However, it is expected to be available very soon.